Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.

Shah T, Casas JP, Cooper JA, Tzoulaki I, Sofat R, McCormack V, Smeeth L, Deanfield JE, Lowe GD, Rumley A, Fowkes FG, Humphries SE, Hingorani AD.

Int J Epidemiol. 2009 Feb;38(1):217-31. doi: 10.1093/ije/dyn217. Epub 2008 Oct 17. Review. Erratum in: Int J Epidemiol. 2009 Jun;38(3):890.

2.
3.

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P, Herrington DM.

JAMA. 2012 Aug 22;308(8):788-95. doi: 10.1001/jama.2012.9624.

4.
5.

Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.

Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jöckel KH, Burke GL, Wong ND, Lehmann N, Herrington DM, Möhlenkamp S, Greenland P.

Atherosclerosis. 2014 Oct;236(2):411-7. doi: 10.1016/j.atherosclerosis.2014.07.035. Epub 2014 Aug 14.

6.

Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis.

Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ.

Eur J Prev Cardiol. 2014 Oct;21(10):1233-41. doi: 10.1177/2047487313492065. Epub 2013 May 20.

7.

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.

Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):92-7. doi: 10.1161/CIRCOUTCOMES.108.831198. Epub 2008 Nov 9.

8.

Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study.

Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y.

J Atheroscler Thromb. 2014;21(8):784-98. Epub 2014 Mar 25.

9.

[Role of novel risk factors in predicting risk of ischemic cardiovascular diseases in middle aged men in twenty years in Shanghai].

Jin X, Zhou J, Zhou J, Pan X, Chen H, Ge J.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):335-8. doi: 10.3760/cma.j.issn.0254-6450.2016.03.008. Chinese.

PMID:
27005531
10.

Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population.

Beaney KE, Cooper JA, Ullah Shahid S, Ahmed W, Qamar R, Drenos F, Crockard MA, Humphries SE.

PLoS One. 2015 Jul 2;10(7):e0130754. doi: 10.1371/journal.pone.0130754. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139651.

11.

The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.

Shiffman D, O'Meara ES, Rowland CM, Louie JZ, Cushman M, Tracy RP, Devlin JJ, Psaty BM.

BMC Cardiovasc Disord. 2011 Mar 15;11:10. doi: 10.1186/1471-2261-11-10.

12.

Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.

Rana JS, Cote M, Després JP, Sandhu MS, Talmud PJ, Ninio E, Wareham NJ, Kastelein JJ, Zwinderman AH, Khaw KT, Boekholdt SM.

Heart. 2009 Oct;95(20):1682-7. doi: 10.1136/hrt.2009.170134. Epub 2009 Jul 8.

PMID:
19587389
13.

Screening for heart disease: C-reactive protein versus coronary artery calcium.

Patel AA, Budoff MJ.

Expert Rev Cardiovasc Ther. 2010 Jan;8(1):125-31. doi: 10.1586/erc.09.166. Review.

PMID:
20014938
14.
15.

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.

Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A.

Europace. 2014 Oct;16(10):1426-33. doi: 10.1093/europace/euu175. Epub 2014 Jul 18.

16.

Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.

Herder C, Baumert J, Zierer A, Roden M, Meisinger C, Karakas M, Chambless L, Rathmann W, Peters A, Koenig W, Thorand B.

PLoS One. 2011;6(6):e19852. doi: 10.1371/journal.pone.0019852. Epub 2011 Jun 6.

17.

Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

Simmons RK, Sharp S, Boekholdt SM, Sargeant LA, Khaw KT, Wareham NJ, Griffin SJ.

Arch Intern Med. 2008 Jun 9;168(11):1209-16. doi: 10.1001/archinte.168.11.1209.

PMID:
18541829
18.

C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients.

Bazeley J, Bieber B, Li Y, Morgenstern H, de Sequera P, Combe C, Yamamoto H, Gallagher M, Port FK, Robinson BM.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2452-61. doi: 10.2215/CJN.00710111. Epub 2011 Aug 25.

19.

Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.

Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, Rathod A, Lafferty J.

Int J Cardiol. 2014 Feb 15;171(3):390-7. doi: 10.1016/j.ijcard.2013.12.019. Epub 2013 Dec 23.

PMID:
24388541
20.

Critical appraisal of inflammatory markers in cardiovascular risk stratification.

Krintus M, Kozinski M, Kubica J, Sypniewska G.

Crit Rev Clin Lab Sci. 2014 Oct;51(5):263-79. doi: 10.3109/10408363.2014.913549. Epub 2014 Jun 11. Review.

PMID:
24918900

Supplemental Content

Support Center